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Background: Selection bias is a systematic error in epidemiologic studies that may seriously distort true measures of
associations between exposure and disease. Observational studies are highly susceptible to selection bias, and
researchers should therefore always examine to what extent selection bias may be present in their material and what
characterizes the bias in their material. In the present study we examined long-term participation and consequences of
loss to follow-up in the studies Respiratory Health in Northern Europe (RHINE), Italian centers of European Community
Respiratory Health Survey (I-ECRHS), and the Italian Study on Asthma in Young Adults (ISAYA).
Methods: Logistic regression identified predictors for follow-up participation. Baseline prevalence of 9 respiratory
symptoms (asthma attack, asthma medication, combined variable with asthma attack and/or asthma medication,
wheeze, rhinitis, wheeze with dyspnea, wheeze without cold, waking with chest tightness, waking with dyspnea) and
9 exposure-outcome associations (predictors sex, age and smoking; outcomes wheeze, asthma and rhinitis) were
compared between all baseline participants and long-term participants. Bias was measured as ratios of relative
frequencies and ratios of odds ratios (ROR).
Results: Follow-up response rates after 10 years were 75% in RHINE, 64% in I-ECRHS and 53% in ISAYA. After 20 years
of follow-up, response was 53% in RHINE and 49% in I-ECRHS. Female sex predicted long-term participation (in RHINE
OR (95% CI) 1.30(1.22, 1.38); in I-ECRHS 1.29 (1.11, 1.50); and in ISAYA 1.42 (1.25, 1.61)), as did increasing age. Baseline
prevalence of respiratory symptoms were lower among long-term participants (relative deviations compared to total
baseline population 0-15% (RHINE), 0-48% (I-ECRHS), 3-20% (ISAYA)), except rhinitis which had a slightly higher
prevalence. Most exposure-outcome associations did not differ between long-term participants and all baseline
participants, except lower OR for rhinitis among ISAYA long-term participating smokers (relative deviation 17%
(smokers) and 44% (10–20 pack years)).
Conclusions: We found comparable patterns of long-term participation and loss to follow-up in RHINE, I-ECRHS and
ISAYA. Baseline prevalence estimates for long-term participants were slightly lower than for the total baseline
population, while exposure-outcome associations were mainly unchanged by loss to follow-up.* Correspondence: ane.johannessen@helse-bergen.no
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Figure 1 Flow chart of the RHINE, I-ECRHS and ISAYA studies.
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Large prospective population-based studies provide im-
portant evidence for public health interventions aiming
at early disease prevention and treatment [1,2]. However,
in order to draw valid scientific conclusions, data must
be collected in a way that minimizes systematic errors
[3]. Failing to avoid such errors in data collection could
compromise the internal validity of exposure-outcome
associations, leading to biased effect estimates and erro-
neous conclusions [1,4,5].
In a population-based follow-up study data is collected
repeatedly within the same cohort of study participants.
Inevitably, this study design is vulnerable to loss to follow-
up. If loss to follow-up is greater in some exposure groups
than others, it can affect prevalence estimates and in some
cases also exposure-outcome association estimates [6-9].
Thus, an evaluation of non-response and loss to follow-up
is essential in order to determine the validity and scientific
potential of population-based epidemiological studies.
In 1989, the largest European longitudinal study within
the field of respiratory health was launched; the European
Community Respiratory Health Survey (ECRHS) [10]. In
relation to this study, Northern European countries ini-
tiated a study with postal questionnaires expanding the
baseline ECRHS population to include representative
populations in Iceland, Denmark, Sweden, Norway and
Estonia: the Respiratory Health in Northern Europe
(RHINE) study [11]. Also in Southern Europe study cen-
ters were involved in both the ECRHS as well as formed
separate studies in relation with ECRHS. Italian Study on
Asthma in Young Adults (ISAYA) is one such study [12].
The aim of the present paper was to examine long-
term participation and consequences of loss to follow-up
in Northern European and Italian study centers. We
aimed to identify predictors for long-term participation,
and to quantify bias in selected respiratory outcomes
and exposure-outcome associations.Methods
Study population
The overall aims of RHINE, I-ECRHS and ISAYA are to
identify incidence, prevalence and risk factors for respira-
tory diseases such as asthma and chronic obstructive pul-
monary disease, and symptoms related to such diseases.
RHINE is a large Northern European prospective cohort
study initiated in 1989–1992, with follow-ups in 1999–
2000 and in 2010–2012 (Figure 1). Participating centers in
RHINE are Reykjavik (Iceland), Bergen (Norway), Umeå,
Uppsala and Gothenburg (Sweden), Aarhus (Denmark)
and Tartu (Estonia) [11,13].
The Italian centers included in the ECRHS are Verona,
Pavia and Turin. They were all included in the ECRHS in
1991–93 with a follow-up examination in 1998–2000 [14].Verona also completed a second follow-up in 2008–2009
(Figure 1).
ISAYA was initially conducted in 1998–2000 and com-
prised nine study centers [12]. Of these, two centers,
Verona and Sassari, participated in a follow-up study in
2008–2009 (Figure 1).
We examined data from the total baseline populations
in each of the three studies, and compared them with
baseline data for 10-yrs follow-up populations (subjects
who participated both at baseline and first follow-up in the
studies) and with baseline data for 20-yrs follow-up popu-
lations (subjects who participated both at baseline and
both follow-up examinations in RHINE and I-ECRHS).
We also examined data on associations of smoking with
selected outcomes for all three studies in 1998–2000 (first
follow-up study for RHINE and I-ECRHS, and baseline for
ISAYA) and compared them with the same data for 10-yrs
follow-up populations. The selection of 1998–2000 data
for these exposure-outcome analyses was due to missing
smoking information at baseline for RHINE and I-ECRHS.
In all studies, informed consent was obtained from
each participant prior to each stage, and the studies were
approved by regional committees of medical research
ethics according to national legislations. For exact names
on the regional ethics committees in each study centre,
please see information in the online supplement.
Selected outcomes and exposures
The data used for the present study was collected
through questionnaires with the same questions in all
three studies. In RHINE, the data was collected through
self-administered questionnaires, while in the Italian
studies the data was collected partly through self-admi-
nistered questionnaires (66% in I-ECRHS and 72% in
ISAYA) and partly by telephone interviews (44% in
I-ECRHS and 28% in ISAYA) [14,15]. Main outcomes
for the present study were wheeze, asthma and rhinitis
(see online supplement for exact question wording). In
Table 1 Response rates by study centres at baseline and
follow-up stagesa
Study center Baseline 10-yrs follow-up 20-yrs follow-up
RHINE
Aarhus 3614 (85%) 2 589 (72%) 1959 (54%)
Bergen 3449 (82%) 2 506 (73%) 1833 (53%)
Gothenburg 2861 (83%) 2 175 (76%) 1496 (52%)
Reykjavik 2899 (84%) 1 967 (68%) 1572 (54%)
Tartu 2449 (85%) 1 705 (70%) 1066 (44%)
Umea 3273 (92%) 2 621 (80%) 1745 (53%)
Uppsala 3114 (89%) 2 543 (82%) 1770 (57%)
TOTAL 21 659 (86%) 16 106 (75%) 11 441 (53%)
Italian ECRHS
Verona 2711 (92%) 1737 (64%) 1338 (49%)
Pavia 816 (86%) 701 (86%) -
Turin 2502 (84%) 1443 (58%) -
TOTAL 6 029 (88%) 3 881 (64%) 1338 (49%)b
ISAYA
Verona 2158 (74%) 1421 (66%) -
Sassari 2053 (70%) 810 (39%) -
TOTAL 4 211 (72%) 2 231 (53%) -
aSubjects who have answered one or more of the following questions at each of
the relevant study stages: asthma, hay fever, wheeze. Baseline: 1989–92 in RHINE,
1991–93 in Italian ECRHS, 1998–2000 in ISAYA. 10-yrs follow-up: 1999–2000 in
RHINE, 1998-2000 in Italian ECRHS, 2008–09 in ISAYA. 20-yrs follow-up: 2010–12
in RHINE, 2008–09 in Italian ECRHS.
Response rates are calculated based on those invited to baseline for baseline
populations, and based on those participating in baseline for follow-up
populations.
bResponse rate for 20-yrs follow-up in Italian ECRHS is calculated based on
original response rate in Verona.
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valence of other respiratory symptoms: wheeze with dys-
pnea, wheeze without cold, waking with chest tightness,
waking with dyspnea, asthma attack last 12 months, and
current asthma medication.
Selected exposure variables were sex and age at base-
line, as well as study center. In addition, we inspected
associations of wheeze, asthma, rhinitis with smoking
exposure. Smoking variables were self-reported never/
ex/current smoker, and smokers defined as <10 pack
years, 10–20 pack years and ≥20 pack years, with one
pack year being defined as having smoked 20 cigarettes
a day for one year.
Statistical methods
All analyses were performed using Stata/SE version 12.1
(StataCorp, Texas, USA) software for Windows. Logistic
regression analyses were performed to estimate associa-
tions of age, sex and study center with long-term parti-
cipation, using a binary indicator of participation in
follow-up (0 = no, 1 = yes) as dependent variable.
When examining if prevalence and association estimates
differed between all baseline and long-term participants,
we followed methods used by among others Nilsen et al.,
using baseline data as the reference [8,16-19]. The me-
thodology used by Nilsen et al. is described in detail in the
remainder of this section, applying it to the focus of inter-
est in the present study. We estimated baseline prevalence
(with 95% confidence intervals) of all respiratory out-
comes for all baseline participants, for those who partici-
pated at baseline and first follow-up (10-yrs follow-up),
and for those who participated at baseline and both
follow-ups (20-yrs follow-up). We assessed ratios of base-
line prevalence of long-term participants over all baseline
participants, in order to examine potential bias in preva-
lence between these various populations. The 9 selected
exposure-outcome associations were investigated through
logistic regression analyses, and ratios of baseline ORs
among the various forms of long-term participants over
all baseline participants were calculated [8,16,18]. In both
ratios of prevalence estimates and ratios of ORs, a ratio
below 1 indicates under-estimation in the subsample com-
pared to the total baseline population (long-term partici-
pants have a lower prevalence or weaker exposure-
outcome association than all baseline participants), while
a ratio above 1 indicates an over-estimation (long-term
participants have a higher prevalence or stronger expo-
sure-outcome association). For ratios of ORs, this inter-
pretation is reversed if the exposure has a protective effect
on the outcome.
For both ratios of prevalence estimates and ratios of
ORs, we computed 95% confidence intervals to assess the
uncertainty of the ratio through bootstrapping [20]. For
each of the studies, we identified long-term participants(n) and the remainder of the baseline population (m) in
the total baseline population data file (m + n). We per-
formed 2000 random re-samplings from the total baseline
population, and created 2000 alternative data sets with
size m + n. For each sample, we computed the ratios of
long-term participants (n) over all baseline participants
(m + n). By extracting the 2.5 percentile and the 97.5 per-
centile from these 2000 ratio estimates, we retrieved the
95% confidence interval.
Results
Response rates
In RHINE, the baseline study in 1989–1992 comprised
21 659 subjects aged 20–44 yrs (Table 1). In the first
follow-up in 1999–2000, 75% answered a new question-
naire. In the second follow-up in 2010-12, response rate
among those who had participated in the previous two
stages was 53%.
In I-ECRHS centers, the baseline study in 1991–93
comprised 6 029 subjects aged 20–45 yrs. In the first
follow-up in 1998–2000, response rate was 64%, and
Table 2 Predictors for long-term participation in RHINE,
Italian ECRHS and ISAYA, odds ratios with 95%
confidence intervals
Study centre 10-yrs follow-up 20-yrs follow-up
RHINE 20-25 yrs Ref Ref
25-30 yrs 1.18 (1.08, 1.29) 1.15 (1.06, 1.24)
30-35 yrs 1.30 (1.19, 1.42) 1.31 (1.20, 1.42)
35-40 yrs 1.33 (1.21, 1.46) 1.40 (1.29, 1.52)
40-44 yrs 1.55 (1.40, 1.72) 1.59 (1.45, 1.73)
Men Ref Ref
Women 1.30 (1.22, 1.38) 1.28 (1.21, 1.35)
Aarhus 1.22 (1.10, 1.36) 1.50 (1.35, 1.66)
Bergen 1.29 (1.16, 1.44) 1.44 (1.30, 1.60)
Gothenburg 1.52 (1.35, 1.70) 1.37 (1.22, 1.52)
Reykjavik Ref 1.47 (1.31, 1.64)
Tartu 1.14 (1.01, 1.28) Ref
Umea 1.93 (1.72, 2.17) 1.42 (1.28, 1.58)
Uppsala 2.14 (1.90, 2.41) 1.65 (1.48, 1.83)
Italian 20-25 yrs Ref Ref
ECRHS 25-30 yrs 0.91 (0.77, 1.07) 0.96 (0.76, 1.22)
30-35 yrs 1.07 (0.90, 1.27) 1.27 (1.00, 1.63)
35-40 yrs 1.29 (1.08, 1.54) 1.50 (1.17, 1.92)
40-44 yrs 1.50 (1.26, 1.80) 1.63 (1.26, 2.09)
Men Ref Ref
Women 1.18 (1.06, 1.31) 1.29 (1.11, 1.50)
Verona 1.33 (1.19, 1.49) -
Pavia 4.48 (3.62, 5.55) -
Turin Ref -
ISAYA 20-25 yrs Ref -
25-30 yrs 1.08 (0.89, 1.32) -
30-35 yrs 1.19 (0.97, 1.45) -
35-40 yrs 1.29 (1.05, 1.60) -
40-44 yrs 1.19 (0.96, 1.47) -
Men Ref -
Women 1.42 (1.25, 1.61) -
Verona 2.93 (2.59, 3.33) -
Sassari Ref -
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the second follow-up in 2008–09.
In ISAYA, 4 211 subjects aged 20–45 yrs participated
at baseline in 1998–2000. At follow-up 10 yrs later, 53%
participated. The initial response rates at baseline were
high across all centres, varying from 70% in Sassari
(Italy) to 92% in Umeå (Sweden) and Verona (Italy)
(Table 1, [12,21]). Ten years later, response rates varied
from 39% in Sassari (Italy) to 86% in Pavia (Italy). When
looking at participants 20 years after baseline, response
rates varied from 44% in Tartu (Estonia) to 57% in
Uppsala (Sweden).
Determinants of participation
Table 2 presents associations of age, sex and study cen-
ter, with 10-yrs and 20-yrs follow-up participation,
respectively. OR for long-term participation increased
with increasing age, especially in RHINE and I-ECRHS.
Women were more often long-term participants than
men in all three studies. The propensity to participate
varied significantly across centers: the OR for long-term
participation in RHINE was especially high in Umea and
Uppsala for 10-yrs follow-up, and in Aarhus and Uppsala
for 20-yrs follow-up. In I-ECRHS and in ISAYA, Pavia and
Verona had the highest ORs for long-term participation,
respectively.
Baseline prevalence of respiratory symptoms
Prevalence estimates of wheeze, asthma and rhinitis at
baseline are shown in Table 3 and in Additional file 1:
e-Table S1 in the online supplement for each study
center separately. Baseline prevalence of several other
respiratory symptoms is presented in the online supple-
ment (Additional file 1: e-Table S2). In RHINE, preva-
lence of baseline wheeze last 12 months, wheeze with
dyspnea, wheeze without cold, waking with chest tight-
ness and waking with dyspnea were significantly lower
in the long-term participants compared to the total
baseline population, while the prevalence of rhinitis was
higher. Waking with dyspnea had a relative deviation of
15% between the 20-yrs follow-up participants and the
total baseline population, while all other symptoms dif-
fered by <10% between the long-term population and
the total baseline population.
In I-ECRHS, the 10-yrs follow-up population and the
total baseline population did not differ in baseline pre-
valence of any of the respiratory outcomes. Regarding
20-yrs follow-up, however, baseline prevalence of rhinitis
was higher compared to the corresponding estimate in
the total baseline population (relative deviation 14%),
while wheeze with dyspnea and waking with dyspnea
was lower (relative deviations 48% and 23%, respec-
tively). In ISAYA, baseline prevalence of wheeze last
12 months, wheeze with dyspnea and waking with chesttightness was lower in the 10-yrs follow-up population
compared to the total baseline population (relative de-
viations 9%, 20% and 11%, respectively).
A closer look at the study centers (Additional file 1:
e-Table S1) shows more heterogeneous study centers in
RHINE than in I-ECRHS and ISAYA. In Reykjavik, base-
line asthma and rhinitis was higher in long-term partici-
pants compared to total baseline population, the same
was true for rhinitis in Tartu and Umea. Aarhus, Bergen,
Gothenburg and Tartu had lower baseline prevalence of
Table 3 Prevalence (with 95% confidence intervals) of respiratory symptoms at baseline in total baseline population,
population at 10-yrs follow-up and population at 20-yrs follow-up, and differences between these groups given as
ratios of baseline symptom prevalence (with bootstrapped 95% confidence intervals) in population at 10-yrs follow-up
over total baseline population, and in population at 20-yrs follow-up over total baseline populationa
Baseline population
(95%CI)
10-yrs follow-up
population (95%CI)
Ratio of prevalences
(95%CI)b
20-yrs follow-up
population (95%CI)
Ratio of prevalences
(95%CI)b
Wheeze RHINE 22.2% (20.4, 21.6) 21.5% (19.9, 21.3) 0.97 (0.95, 0.99) 20.5% (19.0, 20.6) 0.92 (0.90, 0.95)
Italian ECRHS 10.0% (9.0, 10.5) 10.2% (8.9, 10.8) 1.02 (0.96, 1.07) 10.1% (8.0, 11.2) 1.01 (0.87, 1.14)
ISAYA 15.1% (12.4, 14.6) 13.7% (11.1, 13.8) 0.91 (0.84, 0.98) - -
Asthma RHINE 4.7% (4.3, 5.0) 4.8% (4.4, 5.2) 1.02 (0.99, 1.05) 4.6% (4.3, 5.1) 0.98 (0.92, 1.03)
Italian ECRHS 4.2% (3.6, 4.6) 4.2% (3.5, 4.7) 1.00 (0.91, 1.09) 3.8% (2.5, 4.5) 0.90 (0.67, 1.10)
ISAYA 5.3% (4.4, 5.8) 5.0% (3.8, 5.6) 0.94 (0.83, 1.07) - -
Rhinitis RHINE 19.3% (19.3, 20.5) 19.8% (19.7, 21.1) 1.03 (1.01, 1.04) 19.9% (19.9, 21.5) 1.03 (1.00, 1.06)
Italian ECRHS 15.9% (14.8, 16.6) 15.8% (14.4, 16.7) 0.99 (0.95, 1.03) 18.2% (15.8, 20.0) 1.14 (1.02, 1.26)
ISAYA 20.7% (19.3, 21.8) 21.1% (19.3, 22.7) 1.02 (0.96, 1.08) - -
aTotal baseline population: participants in 1989–92 in RHINE, 1991–93 in Italian ECRHS, 1998–2000 in ISAYA. 10-yrs follow up population: participants in 1999-2000
in RHINE and 1998–2000 in Italian ECRHS, 2008–09 in ISAYA. 20-yrs follow-up population: participants in 2010-12 in RHINE, 2008–09 in Italian ECRHS.
bCorrected for inter-dependency between long-term participants and total baseline participants, by using a non-parametric bootstrap method. Significant differences
between long-term participants and all baseline participants are marked in bold font.
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baseline participants, for Aarhus this was also the case
with asthma.Associations of age and sex with respiratory outcomes
Table 4 shows ORs for age (5-year-intervals) and female
sex with regard to baseline wheeze, asthma and rhinitis in
RHINE, I-ECRHS and ISAYA, and ratios of ORs between
long-term and total baseline participants. There were no
significant differences between the ORs of long-term par-
ticipants and the ORs of all baseline participants in any of
the three studies. When stratified by study centers, associa-
tions for long-term participants and total baseline partici-
pations were more diverse, especially for Pavia, Aarhus and
Reykjavik (Additional file 1: e-Table S3 and e-Table S4).Associations of smoking with respiratory outcomes
In the studies performed in 1998–2000, information on
smoking habits was included in RHINE, I-ECRHS and
ISAYA. Tables 5, 6 and 7 show ORs for associations of
smoking exposure with wheeze, asthma and rhinitis, re-
spectively, as well as the ratios of ORs between 10-yrs
follow-up participants and total baseline participants.
There was increased OR for wheeze with smoking in all
three studies. The ORs differed slightly between 10-yrs
follow-up participants and total baseline participants, but
all relative differences were below 15% and not statistically
significant (Table 5). There were no significant associa-
tions between smoking and asthma in the three studies,
with the exception of an association between ex-smokers
and asthma in I-ECRHS (Table 6). None of the ORs bet-
ween long-term participants and total baseline population
differed significantly from each other.Current smoking and smoking more than 10 pack
years were both associated with a lower OR for rhinitis
in all study centers (Table 7). In RHINE and I-ECRHS
there were no differences in ORs between long-term and
all baseline participants, while the OR of current
smokers and subjects with 10–20 pack years were sig-
nificantly lower for long-term than all baseline par-
ticipants in ISAYA (17% and 44% relative difference,
respectively).
Discussion
The present study of long-term participation in RHINE,
I-ECRHS and ISAYA showed that increasing age and fe-
male sex were predictors for long-term participations.
When comparing long-term participants to all baseline
participants, we found lower baseline prevalence of se-
veral respiratory symptoms among long-term partici-
pants compared to all baseline participants. However,
analyses of exposure-outcome associations showed only
minor differences between long-term participants and all
baseline participants.
Characteristics and bias associated with long-term
association
That older people and women are more prone to partici-
pate in follow-up studies than younger subjects and men
is in line with previous studies [22-27]. Several studies
have furthermore shown that non-responders tend to be
smokers to a larger degree than responders [22,25-28]. At
the baseline studies in RHINE and I-ECRHS, we did not
have information on smoking habits among responders
and non-responders, but a previous report from ISAYA
showed that smokers were over-represented among late
responders compared to early responders [15].
Table 4 Associations between increasing age (5-year intervals) and female sex and the respiratory symptoms wheeze,
asthma and rhinitis at baseline (odds ratios with 95% confidence intervals) in total baseline population, population at
10-yrs follow-up and population at 20-yrs follow-up, and differences between these groups given as ratios of odds
ratios (with bootstrapped 95% confidence intervals) in population at 10-yrs follow-up over total baseline population,
and in population at 20-yrs follow-up over total baseline populationa
Baseline population
OR (95%CI)
10-yrs follow-up
population OR (95%CI)
Ratio of ORs
(95%CI)b
20-yrs follow-up
population OR (95%CI)
Ratio of ORs
(95%CI)b
Wheeze Age RHINE 1.00 (0.98, 1.02) 1.01 (0.98, 1.03) 1.01 (0.99, 1.02) 0.98 (0.95, 1.02) 0.98 (0.96, 1.01)
Italian ECRHS 1.10 (1.03, 1.17) 1.10 (1.02, 1.19) 1.00 (0.96, 1.05) 1.15 (1.01, 1.31) 1.05 (0.93, 1.18)
ISAYA 0.97 (0.91, 1.03) 0.96 (0.88, 1.05) 0.99 (0.94, 1.07) - -
Sex RHINE 0.95 (0.90, 1.02) 0.99 (0.92, 1.07) 1.04 (1.00, 1.08) 0.96 (0.87, 1.05) 1.01 (0.94, 1.07)
Italian ECRHS 0.76 (0.64, 0.90) 0.74 (0.60, 0.91) 0.97 (0.86, 1.10) 0.63 (0.44, 0.91) 0.83 (0.60, 1.15)
ISAYA 0.81 (0.69, 0.96) 0.79 (0.62, 1.01) 0.98 (0.82, 1.16) - -
Asthma Age RHINE 0.98 (0.93, 1.02) 0.98 (0.93, 1.03) 1.00 (0.97, 1.03) 0.96 (0.90, 1.02) 0.98 (0.94, 1.03)
Italian ECRHS 0.99 (0.90, 1.08) 0.94 (0.84, 1.05) 0.95 (0.89, 1.01) 0.88 (0.71, 1.08) 0.89 (0.73, 1.06)
ISAYA 0.92 (0.83, 1.02) 0.95 (0.83, 1.09) 1.03 (0.93, 1.15) - -
Sex RHINE 1.16 (1.02, 1.32) 1.21 (1.05, 1.40) 1.04 (0.97, 1.13) 1.13 (0.95, 1.35) 0.97 (0.87, 1.11)
Italian ECRHS 0.84 (0.66, 1.08) 0.82 (0.60, 1.12) 0.98 (0.80, 1.18) 0.60 (0.34, 1.06) 0.71 (0.41, 1.18)
ISAYA 1.08 (0.82, 1.41) 0.94 (0.64, 1.38) 0.87 (0.67, 1.16) - -
Rhinitis Age RHINE 0.97 (0.95, 0.99) 0.97 (0.95, 1.00) 1.00 (0.99, 1.02) 0.97 (0.94, 1.00) 1.00 (0.98, 1.02)
Italian ECRHS 0.94 (0.89, 0.99) 0.93 (0.88, 0.99) 0.99 (0.96, 1.03) 0.91 (0.83, 1.01) 0.97 (0.89, 1.07)
ISAYA 0.93 (0.88, 0.98) 0.91 (0.84, 0.98) 0.98 (0.93, 1.03) - -
Sex RHINE 0.99 (0.92, 1.05) 1.01 (0.93, 1.09) 1.02 (0.98, 1.06) 1.01 (0.92, 1.11) 1.02 (0.96, 1.09)
Italian ECRHS 0.93 (0.81, 1.07) 0.89 (0.75, 1.06) 0.96 (0.86, 1.06) 0.73 (0.55, 0.97) 0.78 (0.61, 1.01)
ISAYA 0.85 (0.74, 0.99) 0.79 (0.64, 0.97) 0.93 (0.81, 1.06) - -
aTotal baseline population: participants in 1989–92 in RHINE, 1991–93 in Italian ECRHS, 1998–2000 in ISAYA. 10-yrs follow up population: participants in 1999-2000
in RHINE and 1998–2000 in Italian ECRHS, 2008–09 in ISAYA. 20-yrs follow-up population: participants in 2010-12 in RHINE, 2008–09 in Italian ECRHS. bCorrected
for inter-dependency between long-term participants and total baseline participants, by using a non-parametric bootstrap method. Significant associations
between risk factors and respiratory symptoms are marked in bold font, as well as significant differences between long-term participants and all
baseline participants.
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http://www.biomedcentral.com/1471-2466/14/63Many studies report response rates as an indicator of
the data generalizability. However, it has been pointed
out that even studies with high response rates may have
biased effect estimates if the non-response is not ran-
dom [7]. Results from the present study indicated that
long-term participants had less respiratory symptoms
compared to all baseline participants in RHINE, ISAYA
and I-ECRHS, with the exception of rhinitis. In the
literature, we find studies that are both in accordance
and in discordance with our results [14,15,22,25,28-30].
These differences between studies show the importance
of assessing selection bias in every longitudinal study, ra-
ther than simply stating the response rate [26,31].
Interestingly, two of the reports that are in contradic-
tion with the results from our study are from I-ECRHS
and ISAYA [14,15]. These reports showed that there was
a higher prevalence of respiratory symptoms among
early responders than late responders in baseline ISAYA
and I-ECRHS, and a higher symptom prevalence among
those who participated in both the screening part and
the clinical part of the baseline ECRHS than among
those who participated only in the screening part. Thatthe Italian papers have focused on late responders at
baseline may partly explain the diverging results regar-
ding symptom prevalence. Although responding late,
they were baseline participants, and as such these sub-
jects are included in the total baseline population of the
present study. Also, even if those who participated in the
screening questionnaire but refused to take part in the
clinical part of the baseline ECRHS can be defined as
non-responders in the clinical study, the follow-up time
between these two parts of the baseline ECRHS was
short and consequently not comparable to the present
study.
In both RHINE and I-ECRHS we defined 20-yrs follow-
up participation as subjects who participated at baseline
and both follow-up studies. This response rate was 53% in
RHINE, but a noteworthy proportion of subjects partici-
pated at baseline and at the second follow-up, but not in
the first follow-up. If considering participants who were
part of the baseline and the second follow-up study, re-
gardless of participation in the first follow-up study, the
20-yrs response rate in RHINE was raised from 53% to
61% (13 128 participants). Additional analyses showed
Table 5 Associations between smoking status and pack years and wheeze at baseline (odds ratios with 95%
confidence intervals) in total baseline population and population at 10-yrs follow-up, and differences between these
groups given as ratios of odds ratios (with bootstrapped 95% confidence intervals) in population at 10-yrs follow-up
over total baseline populationa
Baseline population OR (95%CI) 10-yrs follow-up population OR (95%CI) Ratio of ORs (95%CI)b
Ex-smokers RHINE 1.26 (1.13, 1.40) 1.26 (1.11, 1.44) 1.00 (0.93, 1.08)
Italian ECRHS 1.46 (0.94, 2.27) 1.53 (0.95, 2.48) 1.05 (0.86, 1.28)
ISAYA 1.99 (1.53, 2.60) 2.11 (1.46, 3.05) 1.06 (0.81, 1.37)
Current smokers RHINE 3.12 (2.84, 3.42) 3.21 (2.87, 3.59) 1.03 (0.97, 1.10)
Italian ECRHS 3.31 (2.32, 4.72) 3.18 (2.13, 4.75) 0.96 (0.79, 1.17)
ISAYA 3.65 (2.99, 4.45) 3.87 (2.92, 5.12) 1.06 (0.87, 1.31)
1-10 pack years RHINE 1.69 (1.53, 1.86) 1.71 (1.51, 1.92) 1.01 (0.94, 1.08)
Italian ECRHS 1.58 (1.03, 2.41) 1.67 (1.05, 2.67) 1.06 (0.87, 1.30)
ISAYA 2.50 (2.03, 3.08) 2.71 (2.02, 3.64) 1.08 (0.88, 1.33)
10-20 pack years RHINE 2.91 (2.57, 3.31) 2.92 (2.50, 3.40) 1.00 (0.92, 1.09)
Italian ECRHS 2.77 (1.76, 4.35) 2.60 (1.56, 4.33) 0.94 (0.71, 1.20)
ISAYA 3.95 (3.01, 5.19) 3.98 (2.66, 5.96) 1.01 (0.73, 1.36)
20+ pack years RHINE 4.37 (3.75, 5.10) 3.99 (3.30, 4.82) 0.91 (0.82, 1.02)
Italian ECRHS 4.36 (2.73, 6.98) 3.70 (2.16, 6.34) 0.85 (0.64, 1.10)
ISAYA 7.69 (5.49, 10.76) 7.89 (4.87, 12.80) 1.03 (0.71, 1.47)
aTotal baseline population: participants in 1999-2000 in RHINE and 1998–2000 in Italian ECRHS and ISAYA. 10-yrs follow-up population: participants in 2010–12 in RHINE,
2008–09 in Italian ECRHS and ISAYA. bCorrected for inter-dependency between long-term participants and total baseline participants, by using a non-parametric bootstrap
method. Significant associations between risk factors and respiratory symptoms are marked in bold font, as well as significant differences between long-term participants
and all baseline participants.
Table 6 Associations between smoking status and pack years and asthma at baseline (odds ratios with 95% confidence
intervals) in total baseline population and population at 10-yrs follow-up, and differences between these groups given
as ratios of odds ratios (with bootstrapped 95% confidence intervals) in population at 10-yrs follow-up over total
baseline populationa
Baseline population OR (95%CI) 10-yrs follow-up population OR (95%CI) Ratio of ORs (95%CI)b
Ex-smokers RHINE 1.05 (0.89, 1.22) 1.09 (0.91, 1.31) 1.04 (0.95, 1.14)
Italian ECRHS 1.69 (1.01, 2.83) 1.93 (1.11, 3.36) 1.14 (0.94, 1.42)
ISAYA 1.35 (0.94, 1.95) 1.47 (0.90, 2.40) 1.09 (0.75, 1.47)
Current smokers RHINE 1.08 (0.92, 1.25) 1.02 (0.84, 1.24) 0.94 (0.84, 1.07)
Italian ECRHS 0.72 (0.40, 1.31) 0.67 (0.33, 1.36) 0.93 (0.60, 1.31)
ISAYA 0.94 (0.68, 1.28) 0.71 (0.44, 1.15) 0.76 (0.51, 1.07)
1-10 pack years RHINE 1.04 (0.89, 1.21) 1.11 (0.93, 1.34) 1.07 (0.97, 1.18)
Italian ECRHS 1.35 (0.80, 2.30) 1.59 (0.89, 2.84) 1.18 (0.91, 1.50)
ISAYA 1.18 (0.88, 1.60) 1.09 (0.72, 1.67) 0.92 (0.67, 1.22)
10-20 pack years RHINE 1.04 (0.84, 1.30) 1.07 (0.82, 1.40) 1.03 (0.88, 1.18)
Italian ECRHS 0.77 (0.35, 1.68) 0.72 (0.29, 1.76) 0.94 (0.48, 1.35)
ISAYA 0.91 (0.56, 1.46) 0.84 (0.41, 1.69) 0.92 (0.49, 1.49)
20+ pack years RHINE 1.19 (0.91, 1.56) 1.05 (0.74, 1.48) 0.88 (0.69, 1.08)
Italian ECRHS 0.68 (0.29, 1.61) 0.58 (0.21, 1.57) 0.85 (0.41, 1.26)
ISAYA 0.71 (0.35, 1.47) 0.45 (0.14, 1.50) 0.63 (0.19, 1.43)
aTotal baseline population: participants in 1999-2000 in RHINE and 1998–2000 in Italian ECRHS and ISAYA. 10-yrs follow-up population: participants in 2010–12 in RHINE,
2008–09 in Italian ECRHS and ISAYA. bCorrected for inter-dependency between long-term participants and total baseline participants, by using a non-parametric
bootstrap method. Significant associations between risk factors and respiratory symptoms are marked in bold font, as well as significant differences between long-term
participants and all baseline participants.
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Table 7 Associations between smoking status and pack years and rhinitis at baseline (odds ratios with 95% confidence
intervals) in total baseline population and population at 10-yrs follow-up, and differences between these groups given
as ratios of odds ratios (with bootstrapped 95% confidence intervals) in population at 10-yrs follow-up over total
baseline populationa
Baseline population OR (95%CI) 10-yrs follow-up population OR (95%CI) Ratio of ORs (95%CI)b
Ex-smokers RHINE 0.92 (0.83, 1.01) 0.92 (0.83, 1.03) 1.00 (0.95, 1.06)
Italian ECRHS 0.97 (0.71, 1.32) 0.93 (0.66, 1.32) 0.96 (0.82, 1.12)
ISAYA 1.10 (0.89, 1.35) 1.03 (0.78, 1.37) 0.94 (0.76, 1.14)
Current smokers RHINE 0.80 (0.73, 0.88) 0.80 (0.71, 0.89) 1.00 (0.94, 1.07)
Italian ECRHS 0.68 (0.51, 0.92) 0.71 (0.50, 1.00) 1.04 (0.87, 1.22)
ISAYA 0.71 (0.60, 0.85) 0.59 (0.46, 0.76) 0.83 (0.69, 0.99)
1-10 pack years RHINE 0.92 (0.84, 1.01) 0.91 (0.81, 1.01) 0.99 (0.93, 1.04)
Italian ECRHS 1.00 (0.75, 1.35) 1.06 (0.76, 1.47) 1.06 (0.90, 1.23)
ISAYA 0.99 (0.84, 1.17) 0.96 (0.76, 1.20) 0.97 (0.83, 1.12)
10-20 pack years RHINE 0.77 (0.67, 0.88) 0.80 (0.68, 0.94) 1.04 (0.96, 1.14)
Italian ECRHS 0.58 (0.38, 0.89) 0.55 (0.34, 0.89) 0.95 (0.72, 1.18)
ISAYA 0.57 (0.43, 0.76) 0.32 (0.20, 0.51) 0.56 (0.36, 0.79)
20+ pack years RHINE 0.67 (0.56, 0.80) 0.69 (0.56, 0.86) 1.03 (0.91, 1.16)
Italian ECRHS 0.63 (0.40, 0.99) 0.62 (0.37, 1.04) 0.98 (0.75, 1.25)
ISAYA 0.41 (0.27, 0.62) 0.29 (0.15, 0.56) 0.71 (0.38, 1.12)
aTotal baseline population: participants in 1999-2000 in RHINE and 1998–2000 in Italian ECRHS and ISAYA. 10-yrs follow-up population: participants in 2010–12 in RHINE,
2008–09 in Italian ECRHS and ISAYA. bCorrected for inter-dependency between long-term participants and total baseline participants, by using a non-parametric
bootstrap method. Significant associations between risk factors and respiratory symptoms are marked in bold font, as well as significant differences between long-term
participants and all baseline participants.
Johannessen et al. BMC Pulmonary Medicine 2014, 14:63 Page 8 of 10
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and exposure-outcome associations remained unchanged
regardless of how we defined 20-yrs follow-up participants
(results not shown).
While baseline prevalence estimates were somewhat
altered when excluding those lost to follow-up in the
present study, the 9 exposure-outcome associations ana-
lysed were mainly unchanged. Such a tendency has also
been noted by others [16,23,32,33], and may indicate
that internal causal associations are less vulnerable to se-
lection bias than prevalence estimates. It should be
noted, however, that the focus of the present paper was
associations at baseline. Exposure-outcome associations
based on one of the follow-up studies with both the
follow-up population and those lost to follow-up in-
cluded might have resulted in different estimates. Since
those lost to follow-up per definition will never be in-
cluded in a follow-up study, this will of course be a
purely theoretical speculation.
Future prevalence reports from RHINE, I-ECRHS and
ISAYA should take the results from the present study into
account and interpret prevalence rates accordingly. For in-
stance, knowing that the baseline prevalence of wheeze in
RHINE was 8% lower among long-term participants than
among the total baseline participants should have conse-
quences for the interpretation of wheeze prevalence in a
later follow-up study. If wheeze prevalence at a follow-upstudy is for instance 25%, we should take into account
that the “true” wheeze prevalence is likely to be approxi-
mately 8% higher, i.e. 27%. Also, knowing that the base-
line prevalence of rhinitis in ISAYA was 14% higher
among long-term participants than among the total
baseline participants would infer a similar interpretation
of rhinitis prevalence in a later follow-up study: a rhi-
nitis prevalence of for instance 20% in a follow-up study
would indicate a “true” rhinitis prevalence to be 14%
higher, i.e. 22.8%.
Bias in baseline prevalence estimates may also have con-
sequences for follow-up estimations on incidence, remis-
sion and in some instances also risks. The lower baseline
prevalence of respiratory symptoms among long-term par-
ticipants as compared to total baseline participants that
we found in the present study may indicate a healthy sur-
vivor effect in the study. Such an effect is most commonly
observed in association with occupation, in that persons
who remain employed tend to be healthier than those
who leave employment. However, it is also plausible that
persons who continue to participate in a study is healthier
than persons who quit their study participation, especially
in a study with such a long follow-up period as the RHINE
and the Italian ECRHS have. Incidence and remission esti-
mates in the follow-up stages of these studies may both be
under-estimated compared to true population estimates if
the follow-up population is generally healthier than the
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find very large variations in baseline prevalence estimates,
and the effects on incidence and remission estimates later
on in the study are consequently likely to be small. Future
incidence investigations based on the three studies co-
vered here should nevertheless take into account the
observed baseline differences between total baseline par-
ticipants and long-term participants in the interpretation
of results.
Merits and limits of the study
The main strengths of this study are 1) the large sample
size, 2) the extensive follow-up time, and 3) the use of a
methodology that is well suited to assess size and direc-
tion of selection bias in long-term follow-up. Certain
limitations should also be acknowledged: firstly, the lack
of information on predictors for baseline participation.
We have examined long-term participation but know lit-
tle of potential selection bias at baseline. Secondly, the
three studies in this report have not been conducted at
exactly the same points in time. This is especially rele-
vant for ISAYA, which started 10 years after ECRHS and
RHINE. However, since the results are essentially the
same between studies with regard to follow-up participa-
tion patterns, we do not believe that the time aspect is
vital in this context. Thirdly, we have focused on a lim-
ited amount of selected exposures and outcomes. To be
sure that loss to follow-up does not bias other effect esti-
mates, all possible exposures and outcomes should in
principle have been examined in the same way. However,
this is not feasible. Although many associations remain
to be analysed, we believe that the selection of different
exposures and outcomes in the present paper gives an
indication of the validity of RHINE, I-ECRHS and
ISAYA.
Conclusions
To conclude, increasing age and female sex were predic-
tors for long-term participation. Prevalence estimates
from the follow-up populations should be interpreted with
some caution in future reports from RHINE, I-ECRHS
and ISAYA since they tended to be slightly lower than for
the total baseline population. Exposure-outcome associa-
tions, on the other hand, were mainly unchanged by loss
to follow-up. Although response rates varied between
studies, the present results indicate high validity in the
data from RHINE, I-ECRHS and ISAYA.
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